Why the study?
Evidence on reported non-invasive parameters and cut-off values for diagnosing coronary microvascular dysfunction in angina patients without obstructive disease is limited.
What are the reported non-invasive imaging parameters and cut-off values for diagnosing coronary microvascular dysfunction in patients with angina pectoris without obstructed coronary arteries?
Systematic Review
What are the reported non-invasive imaging parameters and cut-off values for diagnosing coronary microvascular dysfunction in patients with angina pectoris without obstructed coronary arteries?
This systematic review summarizes current evidence on non-invasive imaging parameters (CMR, PET, TTE) for diagnosing coronary microvascular dysfunction, highlighting significant overlap between patients and controls and a need for standardized methodology.
Background: Coronary microvascular dysfunction (CMD) is an important underlying cause of angina pectoris. Currently, no diagnostic tool is available to directly visualize the coronary microvasculature. Invasive microvascular reactivity testing is the diagnostic standard for CMD, but several non-invasive imaging techniques are being evaluated. However, evidence on reported non-invasive parameters and cut-off values is limited. Thus, we aimed to provide an overview of reported non-invasive parameters and corresponding cut-off values for CMD. Methods: Pubmed and EMBASE databases were systematically searched for studies enrolling patients with angina pectoris without obstructed coronary arteries, investigating at least one non-invasive imaging technique to quantify CMD. Methodological quality assessment of included studies was performed using QUADAS-2. Results: Thirty-six studies were included. Nine cardiac magnetic resonance (CMR) studies reported MPRI ( n = 9) and nine positron emission tomography (PET) and transthoracic echocardiography (TTE) studies reported CFR. Mean MPRI ranged from 1.47 ± 0.36 to 1.83 ± 0.50 in patients and from 1.50 ± 0.47 to 2.23 ± 0.37 in healthy controls. Reported mean CFR in PET and TTE ranged from 1.39 ± 0.31 to 2.85 ± 1.35 and 1.69 ± 0.40 to 2.40 ± 0.40 for patients, and 2.68 ± 0.83 to 4.32 ± 1.78 and 2.65 ± 0.65 to 3.31 ± 1.10 for controls, respectively. Conclusions : This systematic review summarized current evidence on reported parameters and cut-off values to diagnose CMD for various non-invasive imaging modalities. Nonetheless, standardization of methodology and reporting of outcome measures is required to provide clinically applicable reference values.
No takes yet. Share an insight, caveat, or question.
Groepenhoff et al. (2020) conducted a systematic review in Coronary microvascular dysfunction. Non-invasive imaging (CMR, PET, TTE) vs. Healthy controls was evaluated on Myocardial perfusion reserve index (MPRI) and coronary flow reserve (CFR).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: